計算
ROA | = | 100 | × | 当期純利益(損失)1 | ÷ | 総資産1 | |
---|---|---|---|---|---|---|---|
2022/12/31 | 32.34% | = | 100 | × | 8,362) | ÷ | 25,858) |
2021/12/31 | 49.46% | = | 100 | × | 12,202) | ÷ | 24,669) |
2020/12/31 | -10.18% | = | 100 | × | (747) | ÷ | 7,337) |
2019/12/31 | -32.34% | = | 100 | × | (514) | ÷ | 1,589) |
2018/12/31 | -19.61% | = | 100 | × | (385) | ÷ | 1,962) |
レポートに基づく: 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31).
1 百万米ドル
競合他社との比較
Moderna Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Zoetis Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022/12/31 | 32.34% | 8.53% | 10.06% | 6.53% | 8.55% | 12.62% | 7.27% | 9.57% | 13.30% | 15.91% | 14.85% | 7.15% | 14.16% |
2021/12/31 | 49.46% | 7.88% | 9.63% | 6.40% | 7.73% | 11.44% | 9.16% | 11.47% | 12.35% | 12.11% | 31.75% | 8.12% | 14.65% |
2020/12/31 | -10.18% | 3.07% | 11.54% | -7.61% | 4.79% | 13.28% | 0.18% | 8.41% | 7.72% | 6.23% | 20.47% | 9.23% | 12.04% |
2019/12/31 | -32.34% | 8.84% | 13.13% | 2.65% | 4.85% | 21.17% | 8.74% | 9.59% | 11.66% | 9.72% | 14.29% | 6.33% | 12.99% |
2018/12/31 | -19.61% | 9.58% | 12.64% | 14.06% | 5.54% | 7.36% | 8.57% | 10.00% | 7.53% | 7.00% | 20.83% | 5.22% | 13.25% |
レポートに基づく: 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31).
産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス
Moderna Inc. | 製薬、バイオテクノロジー、ライフサイエンス | |
---|---|---|
2022/12/31 | 32.34% | 10.59% |
2021/12/31 | 49.46% | 10.39% |
2020/12/31 | -10.18% | 5.34% |
2019/12/31 | -32.34% | 9.02% |
2018/12/31 | -19.61% | 8.84% |
レポートに基づく: 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31).
業界との比較: 医療
Moderna Inc. | 医療 | |
---|---|---|
2022/12/31 | 32.34% | 8.35% |
2021/12/31 | 49.46% | 8.24% |
2020/12/31 | -10.18% | 5.46% |
2019/12/31 | -32.34% | 7.22% |
2018/12/31 | -19.61% | 6.17% |
レポートに基づく: 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31).